Species | Experiment | Result |
Human | Lung biopsy | Total mast cell number was increased in IPF lung. |
The number of tryptase and chymase-double-positive mast cells was increased and correlated with the disease severity as measured by FVC. | ||
Plasma | Plasma tryptase, but not chymase levels were markedly increased in patients with severe IPF and negatively correlated with FVC. | |
Rat | Ex vivo | Mast cells reseeded on fibrotic lung matrix released more active and total TGF-β1 in the culture medium compared with mast cells reseeded on non-fibrotic lung matrix. |
Mechanical stretch-induced mast cell degranulation, TGF-β1 release and its signalling pathway activation in fibrotic lung. Mast cell stabilisers attenuated it. | ||
In vivo | Mast cell was increased at well after the fibrogenic process was established, but not at earlier time points. | |
At day 14, chymase and tryptase-double-positive mast cells are few at parenchymal area, however, a small number of chymase-single-positive mast cells accumulated around the bronchial area. By day 21, a significant amount of chymase and tryptase-double-positive mast cells was present in the lung parenchyma. | ||
Cromoglycate attenuated the development of TGF-β1-induced pulmonary fibrosis. |
IPF, idiopathic pulmonary fibrosis; TGF, transforming growth factor.